Skip to main content

Animations

MJFF Publications

3351 - 3360 of 8826 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Brain-restricted mTOR inhibition with binary pharmacology
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-022-05213-y
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-32944-3
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Neurofilament light as a biomarker for motor decline in Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.959261
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-022-00964-1
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-022-01140-3
    Citation Count: 237
  • Summary Details
    OPEN
    Title: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.994114
    Citation Count: 8
  • Summary Details
    OPEN
    Title: GRN Mutations Are Associated with Lewy Body Dementia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29144
    Citation Count: 22
  • Summary Details
    OPEN
    Title: A Markov random field model-based approach for differentially expressed gene detection from single-cell RNA-seq data
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/bib/bbac166
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Interpretable deep learning of myelin histopathology in age-related cognitive impairment
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01425-5
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.977985
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.